NASDAQ NMS - GLOBAL MARKET · DERM
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Journey Medical Corp

Journey Medical Corp

Pharmaceuticals
$7.75
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
DERM
Journey Medical Corp
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

73/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is DERM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading DERM catalysts
About Journey Medical Corp
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
58
Country
US

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.75
Last session
Day high
$7.75
Last session
Day low
$7.75
Last session
Previous close
$7.75
52W high
$9.26
-16.31% from high
52W low
$4.39
69% of range
Market cap
$218.7M
EPS
$-0.3400
Beta
1.56
Shares out
28.2M
Avg volume
208.4K
VWAP
$7.75
Last session
Price history computed in-house
1W
+19.97%
1M
+25.20%
3M
+26.63%
1Y
+3.75%
YTD
+0.52%
SMA 50 $6.68 · above
SMA 200 $6.99 · above
52W position 69%

DERM overview

Veridion Score
73
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around DERM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading DERM Form 4 filings
Public disclosures

Congress activity in DERM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for DERM in the cached public ledger.

Federal contracts

DERM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DERM in this window.
Lobbying spend

DERM lobbying filings, year to date.

Registered lobbying filings matched to Journey Medical Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for DERM in this window.
Loading news for DERM
Analyst ratings
Sovereign unlock shows live analyst consensus for DERM.
Options
Sovereign unlock shows live options positioning for DERM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.